NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
47 hedge funds and large institutions have $47M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $18K
Holders
47
Holding in Top 10
–
Calls
$1K
Puts
$18K
Top Buyers
1 | +$2.25M | |
2 | +$358K | |
3 | +$189K | |
4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$94.7K |
5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$54K |
Top Sellers
1 | -$2.53M | |
2 | -$2.03M | |
3 | -$460K | |
4 |
FM
Frazier Management
Seattle,
Washington
|
-$357K |
5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$292K |